🔎 Trials Near Me

Home › Cutaneous T-Cell Lymphoma

Cutaneous T-Cell Lymphoma clinical trials recruiting in the U.S.

29 studies for Cutaneous T-Cell Lymphoma are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07192471

Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment

RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT01087333

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07195916

A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06854653

Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT04930653

Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT03011814

A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma

Recruiting
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT04045470

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

Recruiting
Ages 18 and older · All sexes · Updated Jul 1, 2026 · NCT06860880

Registry of Older Patients With Cancer

RecruitingObservational study
Ages 65 and older · All sexes · Updated Jun 29, 2026 · NCT01137825

Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 11, 2026 · NCT05313243

A Registry for People With T-cell Lymphoma

RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141

Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas

RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 5, 2026 · NCT05956041

Characterization of the Microbiome in Cutaneous T Cell Lymphoma

RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 89 · All sexes · Updated May 1, 2026 · NCT03932279

Photopheresis in Early-stage Mycosis Fungoides

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 27, 2026 · NCT05680558

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 15, 2026 · NCT07356245

Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 14, 2026 · NCT05996185

Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 1, 2026 · NCT07047885

A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 4, 2026 · NCT05296304

Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29

RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 28, 2026 · NCT04670874

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 30, 2025 · NCT00177268

Amping up With PemJAK

RecruitingPhase 2
Ages 18 to 95 · All sexes · Updated Dec 16, 2025 · NCT07283822

Tissue Repository: CTCL Collection Protocol

RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Nov 4, 2025 · NCT02840747

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.